Lanadelumab And Cardiovascular Risk: Findings From The Phase 3 HELP Study

被引：0
|
作者：
Sexton, Daniel J. [1 ]
Brown, Nancy J. [2 ]
Lumry, William R. [3 ]
Gower, Richard G. [4 ]
Hao, James [1 ]
Lu, Peng [1 ]
Zafra, Heidi T. V. [5 ]
机构：
[1] Shire, Lexington, MA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] AARA Res Ctr, Dallas, TX USA
[4] Marycliff Clin Res, Spokane, WA USA
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
136
引用
收藏
页码：AB46 / AB46
页数：1
相关论文
共 50 条
  • [31] LANADELUMAB EFFICACY AFTER SWITCHING FROM PLACEBO: RESULTS FROM THE HELP AND HELP OPEN-LABEL EXTENSION STUDIES
    Tachdjian, R.
    Anderson, J.
    Busse, P.
    Johnston, D.
    Kiani, S.
    Nurse, C.
    Paes, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S38 - S38
  • [32] Apolipoprotein A-II is a negative risk indicator for cardiovascular and total mortality:: Findings from the Ludwigshafen Risk and Cardiovascular Health study
    Winkler, Karl
    Hoffmann, Michael M.
    Seelhorst, Ursula
    Wellnitz, Britta
    Boehm, Bernhard O.
    Winkelmann, Bernhard R.
    Maerz, Winfried
    Scharnagl, Hubert
    CLINICAL CHEMISTRY, 2008, 54 (08) : 1405 - 1406
  • [33] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [34] Cardiovascular risk burden and disability:findings from the International Mobility in Aging Study(IMIAS)
    Juan-David Martinez-Aristizábal
    Carmen-Lucia Curcio
    Juliana Fernandes
    Afshin Vafael
    Cristiano dos Santos Gomes
    Fernando Gomez
    Journal of Geriatric Cardiology, 2024, 21 (03) : 331 - 339
  • [35] Cardiovascular risk estimation in women on antipsychotics: Findings from a cross- sectional study
    Abhijita, Bandita
    Balasubramanian, Ilambaridhi
    Patra, Chinu
    Mishra, Shree
    Padhy, Susanta Kumar
    INDIAN JOURNAL OF PSYCHIATRY, 2025, 67 : S15 - S15
  • [36] Plasma calprotectin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study
    Kunutsor, Setor K.
    Flores-Guerrero, Jose Luis
    Kieneker, Lyanne M.
    Nilsen, Tom
    Hidden, Clara
    Sundrehagen, Erling
    Seidu, Samuel
    Dullaart, Robin P. F.
    Bakker, Stephan J. L.
    ATHEROSCLEROSIS, 2018, 275 : 205 - 213
  • [37] Depressive Symptoms and Risk of Cardiovascular Events in Blacks Findings From the Jackson Heart Study
    O'Brien, Emily C.
    Greiner, Melissa A.
    Sims, Mario
    Hardy, Natalie Chantelle
    Wang, Wei
    Shahar, Eyal
    Hernandez, Adrian F.
    Curtis, Lesley H.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (06): : 552 - 559
  • [38] LONG-TERM SAFETY OF LANADELUMAB IN HEREDITARY ANGIOEDEMA (HAE): INTERIM RESULTS FROM THE HELP OLE STUDY
    Johnston, D.
    Banerji, A.
    Nurse, C.
    Lu, P.
    Aygoren-Pursun, E.
    Kiani-Alikhan, S.
    Soteres, D.
    Lugar, P.
    Zuraw, B.
    Lockey, R.
    Schwartz, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S30
  • [39] Women, occupation and cardiovascular risk factors: Findings from the Tehran Lipid and Glucose Study
    Ainy, E.
    Azizi, F.
    PUBLIC HEALTH, 2007, 121 (12) : 950 - 953
  • [40] Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
    Maurer, Marcus
    Lumry, William R.
    Li, H. Henry
    Aygoren-Pursun, Emel
    Busse, Paula J.
    Jacobs, Joshua
    Nurse, Christina
    Ahmed, Mariam A.
    Watt, Maureen
    Yu, Ming
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (01) : 201 - 211.e6
12345